🌏 Delivering Specialty Medicines to South-East Asia | ☎ +63 952 488 3302 | ✉ [email protected]
MedsMonk
Login / Register
Sign inCreate an Account

Lost your password?

0 items ₱ 0.00
Menu
MedsMonk
Search
0 items ₱ 0.00
  • Home
  • Medicines
    • Gynecology
    • Hepatitis
    • Men’s Health
    • Oncology
    • Sexual Wellness
    • Women Health
  • Blog
  • Contact Us
  • Track Order
FDA Grants Traditional Approval to Selpercatinib for RET Fusion-Positive Solid Tumors
28 Jul
Understanding Cancer, Diagnosis and Detection, Treatments & Therapies

FDA Grants Traditional Approval to Selpercatinib for RET Fusion-Positive Solid Tumors

  • July 28, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
Medical Disclaimer: The informat...

Continue reading

coloncancer
29 Jun
Uncategorized

EU Approves New Targeted Treatment Combo for Advanced BRAF-Mutant Colon Cancer

  • June 29, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
The European Commission has given the thumbs up to a new combination treatment for advanced bowel cancer. The therapy will use two targ...

Continue reading

14 May
Cancer Medicine, Diagnosis and Detection

Tovorafenib Approved in Europe for Children with BRAF-Altered Low-Grade Glioma

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 14, 2026. nThis marks an important milestone in the treatment o...

Continue reading

06 May
Breast Cancer

FDA Approves Vepdegestrant for ER+/HER2–, ESR1-Mutated Breast Cancer: A New Targeted Option

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 6, 2026. Breast cancer treatment continues to evolve with adva...

Continue reading

Pancreatic Cancer
02 May
Health

How Daraxonrasib Doubled Survival in Pretreated Metastatic Pancreatic Cancer: A Breakthrough Explained

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 2, 2026. nPancreatic cancer remains one of the most aggressive ...

Continue reading

brain tumor
14 Apr
Cancer Medicine

FDA Fast-Tracks Plixorafenib for BRAF V600E–Mutated Brain Tumors

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 14, 2026. nBrain tumors, especially high-grade gliomas, are a...

Continue reading

stages of lung cancer
07 Apr
Cancer Medicine, Lung Cancer, Treatments & Therapies, Understanding Cancer

What are the 4 stages of lung cancer?

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 7, 2026. nLung cancer staging is a critical step in understan...

Continue reading

breast cancer
01 Apr
Breast Cancer, Understanding Cancer

First-Line Palbociclib Combination Boosts PFS in HR+/HER2+ mBC – PATINA Findings

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 1, 2026. nMetastatic breast cancer (mBC) remains a major chal...

Continue reading

lungcancer
25 Mar
Cancer Medicine, Lung Cancer, Understanding Cancer

Sunvozertinib vs Chemo: A PFS Breakthrough in EGFR+ NSCLC

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 25, 2026. nThe treatment landscape for EGFR-mutated non–small...

Continue reading

breast cancer
23 Mar
Breast Cancer, Cancer Medicine, Women Health

Atirmociclib and Fulvestrant Together Delay Cancer Progression in HR+/HER2– Cases

  • May 16, 2026
  • Posted by author-avatar Dr. Sophie Reynolds
  • 0 comments
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 23, 2026. Advancements in breast cancer treatment continue t...

Continue reading

We are on a mission to ensure that every patient has access to affordable medicines for life-threatening conditions, delivered with compassion right to their doorstep.

Call us: +63 952 488 3302

Company

  • About Us
  • Blog/Resources
  • Contact Us
  • Molecules

Speciality Medicines

  • Oncology
  • Gynecology
  • Hepatitis
  • Sexual Wellness
  • Men’s Health
  • Women Health

Most Searched Molecules

  • Tucatinib
  • Osimertinib
  • Ponatinib
  • Ribociclib
  • Eltrombopag

Policy / Legal

  • Terms and Conditions
  • Privacy Policy
  • Grievance Redressal Policy
  • Editorial Policy

Order Policy

  • Order & Payment Policy
  • Cancellation Policy
  • Shipping & Delivery Policy
  • Return & Refund Policy

Country

  • Australia
  • Hong Kong
  • Malaysia
  • Philippines
  • Singapore
  • Thailand

Medical Disclaimer

MedsMonk provides trustworthy, expert-reviewed information for general education only. It is not a substitute for professional medical advice, diagnosis or treatment, and it may not cover every detail of a health condition, lab test, medication, side effect or interaction. Always consult a qualified doctor or pharmacist about your health and before starting, stopping or changing any medicine. Never disregard professional medical advice or delay seeking it because of something you have read here. In an emergency, contact your local emergency services immediately.

  • Facebook

© 2026 MedsMonk. All rights reserved.

  • Home
  • Medicines
    • Gynecology
    • Hepatitis
    • Men’s Health
    • Oncology
    • Sexual Wellness
    • Women Health
  • Blog
  • Contact Us
  • Track Order
  • Login / Register
Shopping cart
Close
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
More info More info Accept
DMRC Complaint Portal